Which is better, tenofovir alafenamide/viride or entecavir?

Tenofovir alafenamide/Veride (TAF) and entecavir (entecavir) are both drugs for the treatment of chronic hepatitis B virus (HBV), and both have been proven safe and effective through clinical trials. When choosing which drug to use, it should be determined based on individual patient differences and the recommendations of professional doctors.

Tenofovir alafenamide fumarate tablets are the latest generation of hepatitis B treatment drugs. Its main ingredient is tenofovir alafenamide (tenofovir alafenamide). Compared with traditional tenofovir disoproxil fumarate, tenofovir disoproxil fumarate tablets can exert the same efficacy at a lower dose and reduce adverse effects on the kidneys. This drug has been shown to be very effective in inhibiting hepatitis B virus replication and improving liver function. Usually taken orally once daily, it is the drug of choice for the treatment of hepatitis B virus in adults and children 6 years and older. Some of the more common side effects include headache, stomach pain, and cough.

Entecavir tablets are another commonly used hepatitis B treatment drug and are nucleoside analogs. It blocks the replication process of the virus by inhibiting the DNA polymerase of hepatitis B virus. Entecavir has high antiviral activity, can significantly reduce viral load, and improve liver function. It is usually taken orally once a day and is suitable for adult patients with chronic hepatitis B. Some side effects of this drug include headache and fatigue.

Tenofovir alafenamide fumarate tablets have a lower dose than entecavir, but have the same efficacy and less adverse effects on the kidneys. The metabolic pathway of entecavir is mainly through the liver, while tenofovir alafenamide fumarate tablets are mainly excreted through bile.